Apyx Medical Corporation APYX
NASDAQ · United States · Health Technology
$2.55+0.05 (+2.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Patients reported high satisfaction and visible improvements in skin elasticity, youthfulness, and radianceCLEARWATER, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical” or the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced results from a prospective clinical study evaluating the effects of Renuvion helium plasma radiofrequency technology on biological markers o
Cold plasma offers opportunities in healthcare, food safety, agriculture, water treatment and manufacturing through chemical-free sterilization, surface engineering and AI-enabled automation.Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Cold Plasma Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Cold Plasma Market research report provides strategic analysis of a market projected to grow from USD 2.39 billion in 2026 to USD 4.09 billion by 2032, at a CAG
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.